These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19756523)

  • 1. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
    Selvaraj S; Murthy NV; Bhagwagar Z; Bose SK; Hinz R; Grasby PM; Cowen PJ
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):555-62. PubMed ID: 19756523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
    van de Giessen E; Rosell DR; Thompson JL; Xu X; Girgis RR; Ehrlich Y; Slifstein M; Abi-Dargham A; Siever LJ
    J Psychiatr Res; 2014 Nov; 58():147-54. PubMed ID: 25145808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
    Boileau I; Warsh JJ; Guttman M; Saint-Cyr JA; McCluskey T; Rusjan P; Houle S; Wilson AA; Meyer JH; Kish SJ
    Mov Disord; 2008 Sep; 23(12):1776-80. PubMed ID: 18661545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
    Reimold M; Smolka MN; Zimmer A; Batra A; Knobel A; Solbach C; Mundt A; Smoltczyk HU; Goldman D; Mann K; Reischl G; Machulla HJ; Bares R; Heinz A
    J Neural Transm (Vienna); 2007; 114(12):1603-9. PubMed ID: 17713719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
    Miller JM; Everett BA; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    Synapse; 2016 Jan; 70(1):24-32. PubMed ID: 26426356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.
    Kraus C; Baldinger P; Rami-Mark C; Gryglewski G; Kranz GS; Haeusler D; Hahn A; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
    PLoS One; 2014; 9(9):e106810. PubMed ID: 25188405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB.
    Burokas A; Martín-García E; Gutiérrez-Cuesta J; Rojas S; Herance JR; Gispert JD; Serra MÁ; Maldonado R
    J Neurochem; 2014 Jul; 130(1):126-35. PubMed ID: 24646401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
    Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
    Gopaldas M; Zanderigo F; Zhan S; Ogden RT; Miller JM; Rubin-Falcone H; Cooper TB; Oquendo MA; Sullivan G; Mann JJ; Sublette ME
    J Affect Disord; 2019 Oct; 257():495-503. PubMed ID: 31319341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.
    Spies M; James GM; Berroterán-Infante N; Ibeschitz H; Kranz GS; Unterholzner J; Godbersen M; Gryglewski G; Hienert M; Jungwirth J; Pichler V; Reiter B; Silberbauer L; Winkler D; Mitterhauser M; Stimpfl T; Hacker M; Kasper S; Lanzenberger R
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):145-153. PubMed ID: 29045739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.